Ingine Inc
www.ingine.comBioIngine.com - Bioinformatics Platform (Ingine Inc venture) Solution driven by Quantum Algebra while residing within the large Patient Health Information Exchange (HIE) works in creating capability for Clinical Efficacy and also facilitates in the better achievement of Efficiencies in the Healthcare Management that ACO seeks. Is an algorithm driven Clinical Decision Support System, that is inherently Evidence Based Medicine. The solution besides enabling EBM also delivers knowledge graphs for Public Health surveys. Innovating from fundamental science has resulted in the development of Data Science to deliver Health Knowledge by Probabilistic Inference. The solution developed addresses following main points besides many others. Interoperability challenges of delivering semantically relevant knowledge both at patient health(clinical) and public health level (ACO). Overcome challenges created by the large data sets; such as uncertainty and high-dimensionality. Advance MU1, MU2 and MU3 goals by addressing risk factors by integrating CDSS into HIE. Overcome some serious inadequacies in the existing methods based on Bayes Net, that does not necessarily deliver AI driven (unsupervised) Knowledge Extraction by Inference that is validated for its coherence. This is significant since we are extracting semantic tags and building semantic triple store from millions of records by automation and machine learning. Features:- Bi-directional Bayesian Probability for knowledge Inference and Biostatistics (Hyperbolic) Built upon medical ontology (in fact this is discovered by machine learning, AI techniques ). Can be both hypothesis and non-hypotheses driven. Quantum probabilities integrating algebra, calculus, vector space, Bayesian knowledge inferencing, Riemann zeta to deal with sparse data and finally driven by overarching Hyperbolic Dirac Net. Builds into web semantics employing NLP. (Integrates both System Dynamics and Systems Thinking) Founding Team:- Srinidhi Boray, CEO and Co-Founder https://www.linkedin.com/in/sboray/ Over 25 years of experience in both entrepreneurial and corporate roles with emphasis on management consulting that includes Enterprise Architecture driven Business Transformation, Large Program Management, Business Development and Sales. Held senior roles and worked across diverse industries including Healthcare. B.E. Electrical Engineering; Dr. Barry Robson, President R&D; CSO and Co-Founder https://www.linkedin.com/in/barry-robson-5913a11b/ PhD in biochemistry and biophysics and a DSc in computational molecular science and quantum mechanics. Specialized in Artificial Intelligence and Decision Support in Medicine. Emeritus Professor of Epidemiology, Biostatistics, and Evidence Based Medicine James Weisman, COO https://www.linkedin.com/in/jim-weisman-48643210/ Over 30 years of experience in the healthcare, financial services, retail and consumer product industries. Previously, he held leadership positions at BioEnterprise (last as CEO-in-Residence), HealthSync, a start-up developing health insurance marketplaces, and Glengary Ventures, a venture fund focused on advanced technology companies. Joseph Casper, Chairman and Managing Director https://www.linkedin.com/in/joseph-casper-817113a/ Mr. Casper; brings 25 years of experience from the healthcare Industry. Has served in senior capacities such as CEO Sandlot Solutions, President and Corporate Officer of FCG (FCGI), EVP of Business development MedPlus, a Quest Diagnostics company.
Read moreBioIngine.com - Bioinformatics Platform (Ingine Inc venture) Solution driven by Quantum Algebra while residing within the large Patient Health Information Exchange (HIE) works in creating capability for Clinical Efficacy and also facilitates in the better achievement of Efficiencies in the Healthcare Management that ACO seeks. Is an algorithm driven Clinical Decision Support System, that is inherently Evidence Based Medicine. The solution besides enabling EBM also delivers knowledge graphs for Public Health surveys. Innovating from fundamental science has resulted in the development of Data Science to deliver Health Knowledge by Probabilistic Inference. The solution developed addresses following main points besides many others. Interoperability challenges of delivering semantically relevant knowledge both at patient health(clinical) and public health level (ACO). Overcome challenges created by the large data sets; such as uncertainty and high-dimensionality. Advance MU1, MU2 and MU3 goals by addressing risk factors by integrating CDSS into HIE. Overcome some serious inadequacies in the existing methods based on Bayes Net, that does not necessarily deliver AI driven (unsupervised) Knowledge Extraction by Inference that is validated for its coherence. This is significant since we are extracting semantic tags and building semantic triple store from millions of records by automation and machine learning. Features:- Bi-directional Bayesian Probability for knowledge Inference and Biostatistics (Hyperbolic) Built upon medical ontology (in fact this is discovered by machine learning, AI techniques ). Can be both hypothesis and non-hypotheses driven. Quantum probabilities integrating algebra, calculus, vector space, Bayesian knowledge inferencing, Riemann zeta to deal with sparse data and finally driven by overarching Hyperbolic Dirac Net. Builds into web semantics employing NLP. (Integrates both System Dynamics and Systems Thinking) Founding Team:- Srinidhi Boray, CEO and Co-Founder https://www.linkedin.com/in/sboray/ Over 25 years of experience in both entrepreneurial and corporate roles with emphasis on management consulting that includes Enterprise Architecture driven Business Transformation, Large Program Management, Business Development and Sales. Held senior roles and worked across diverse industries including Healthcare. B.E. Electrical Engineering; Dr. Barry Robson, President R&D; CSO and Co-Founder https://www.linkedin.com/in/barry-robson-5913a11b/ PhD in biochemistry and biophysics and a DSc in computational molecular science and quantum mechanics. Specialized in Artificial Intelligence and Decision Support in Medicine. Emeritus Professor of Epidemiology, Biostatistics, and Evidence Based Medicine James Weisman, COO https://www.linkedin.com/in/jim-weisman-48643210/ Over 30 years of experience in the healthcare, financial services, retail and consumer product industries. Previously, he held leadership positions at BioEnterprise (last as CEO-in-Residence), HealthSync, a start-up developing health insurance marketplaces, and Glengary Ventures, a venture fund focused on advanced technology companies. Joseph Casper, Chairman and Managing Director https://www.linkedin.com/in/joseph-casper-817113a/ Mr. Casper; brings 25 years of experience from the healthcare Industry. Has served in senior capacities such as CEO Sandlot Solutions, President and Corporate Officer of FCG (FCGI), EVP of Business development MedPlus, a Quest Diagnostics company.
Read moreCountry
State
Virginia
Industry
Employees
1-10
Founded
2015
Estimated Revenue
$1 to $1,000,000
Social
Employees statistics
View all employeesPotential Decision Makers
Chief Executive Officer
Email ****** @****.comPhone (***) ****-****
Technologies
(17)